Back
RenovoRx 10K Form
Sell
30
RNXT
RenovoRx
Last Price:
1.22
Seasonality Move:
-29.56%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RNXT News And Ratings
See the #1 stock for the next 7 days that we like better than RNXT
RNXT Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-2.05M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.28 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -1.01000 |
|---|---|
| Net Income (TTM): | $-10.23M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
RenovoRx Earnings Forecast
Key RenovoRx Financial Ratios
- The Interest Expense is -13.19% of Operating Income.
- Per Share Earnings over the last 5 years have been positive in 3 years.
RenovoRx Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | RNXT |
| Website: | renovorx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |